State of Alaska Department of Revenue Sells 3,135 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

State of Alaska Department of Revenue reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 8.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,261 shares of the biotechnology company’s stock after selling 3,135 shares during the quarter. State of Alaska Department of Revenue’s holdings in Axon Enterprise were worth $10,093,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. ING Groep NV boosted its stake in Axon Enterprise by 9.3% in the fourth quarter. ING Groep NV now owns 9,643 shares of the biotechnology company’s stock worth $2,491,000 after buying an additional 821 shares in the last quarter. Vaughan Nelson Investment Management L.P. boosted its stake in shares of Axon Enterprise by 18.4% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 104,587 shares of the biotechnology company’s stock valued at $27,019,000 after purchasing an additional 16,230 shares in the last quarter. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise during the 4th quarter valued at $32,000. Apollon Wealth Management LLC purchased a new position in Axon Enterprise in the 4th quarter worth $234,000. Finally, Cim LLC purchased a new position in Axon Enterprise in the 4th quarter worth $1,409,000. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 1.2 %

Shares of NASDAQ AXON opened at $296.56 on Thursday. The firm has a fifty day simple moving average of $294.87 and a two-hundred day simple moving average of $285.85. The firm has a market capitalization of $22.38 billion, a PE ratio of 86.71 and a beta of 0.95. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a 12 month low of $175.37 and a 12 month high of $329.87.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. Axon Enterprise’s revenue was up 34.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.51 earnings per share. Equities analysts expect that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Morgan Stanley raised their price objective on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a research note on Friday, April 26th. Craig Hallum raised their price target on Axon Enterprise from $325.00 to $370.00 and gave the stock a “buy” rating in a research report on Tuesday, May 7th. Needham & Company LLC reiterated a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a research report on Tuesday, May 7th. William Blair restated an “outperform” rating on shares of Axon Enterprise in a report on Wednesday, April 24th. Finally, Barclays lifted their target price on shares of Axon Enterprise from $308.00 to $381.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 8th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $335.27.

Insider Activity

In related news, President Joshua Isner sold 44,000 shares of the stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the sale, the president now owns 275,843 shares in the company, valued at approximately $85,500,296.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of Axon Enterprise stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the completion of the sale, the insider now directly owns 189,719 shares of the company’s stock, valued at approximately $58,801,506.86. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Joshua Isner sold 44,000 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the completion of the sale, the president now owns 275,843 shares of the company’s stock, valued at $85,500,296.28. The disclosure for this sale can be found here. Insiders sold 89,447 shares of company stock valued at $27,684,677 in the last ninety days. Insiders own 5.70% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.